Carlo R Settanni

Plain English
This study looked at whether a combination of multistrain probiotics and vitamin D could improve gut health in people with irritable bowel syndrome (IBS) who don't have constipation. Researchers found that after 12 weeks, participants who took the probiotics and vitamin D had a notable decrease in a marker indicating gut permeability (zonulin) and better stool consistency compared to those who took a placebo. Specifically, they experienced a 19.5 ng/mL reduction in zonulin levels and improvements in stool quality and frequency. Who this helps: This helps patients with irritable bowel syndrome, particularly those without constipation.

Plain English
This study examines a rare type of tumor called solitary plasmacytoma, which can appear in the colon and often looks like colon cancer. Researchers reported a case involving an older woman who had a growth in her ascending colon, diagnosed through a colonoscopy, and was treated successfully with surgery. Although this type of tumor is extremely uncommon—affecting fewer than one in ten million people each year—it’s important because misdiagnosis can lead to unnecessary treatments or surgeries for patients. Who this helps: This helps patients who may present with similar symptoms and doctors diagnosing rare colonic tumors.

Plain English
This study looked at what patients with inflammatory bowel disease (IBD) thought about switching from receiving their treatment through an IV in a hospital to self-injecting the medication at home. Out of 311 patients surveyed, nearly half (49.8%) supported the switch, while only about a quarter (25.1%) opposed it. Importantly, many patients didn't realize that most treatments could be given as a shot at home, highlighting the need for better information. Who this helps: This benefits IBD patients, particularly those who would find it easier to manage treatment at home.

Plain English
This study tested a special mixture of probiotics on people with diarrhea-predominant Irritable Bowel Syndrome (IBS-D) and leaky gut. Out of 30 patients, 81.5% showed improved gut health after 30 days, with nearly half returning to normal levels of intestinal permeability. Additionally, participants experienced less abdominal pain and better stool consistency, leading to a significant boost in their quality of life. Who this helps: This benefits patients suffering from IBS-D by providing a potential new treatment option.

Plain English
This study looked at how taking a specific mix of probiotics could help people who recently recovered from COVID-19 by examining their gut health and inflammation levels. After 8 weeks of probiotic treatment, participants showed a significant decrease in inflammatory markers like IL-6 and TNF-α, indicating reduced inflammation, as well as an increase in beneficial gut bacteria. These findings matter because they suggest that probiotics could play a role in improving recovery and reducing inflammation in post-COVID-19 patients. Who this helps: This helps patients recovering from COVID-19.

Plain English
The study looked at how COVID-19 affects the digestive system in older adults, especially those with pre-existing digestive issues. It found that elderly patients often experience severe gastrointestinal symptoms, and the impact of COVID-19 on their digestive health can be significant. Additionally, the study discusses how well COVID-19 vaccines work for patients with digestive disorders and notes specific concerns for older adults. Who this helps: This information benefits elderly patients and their healthcare providers.

Plain English
This study looked at whether switching patients with inflammatory bowel disease (IBD) from receiving a medication called vedolizumab intravenously (through a vein) to a subcutaneous (injection under the skin) form was effective and safe. After 24 weeks, 89.2% of the 93 patients who switched maintained their health without needing steroids, and while there were some side effects, they were mostly manageable. This change could help make treatment easier and less costly for patients. Who this helps: Patients with inflammatory bowel disease.

Plain English
This study investigated how the gut microbiome affects the success of immunotherapy for melanoma, a type of skin cancer. Researchers found that certain gut bacteria can influence how well patients respond to treatment and may also cause side effects like colitis. Understanding these connections can lead to better treatment strategies, potentially improving outcomes for patients; for example, using probiotics or fecal transplants to enhance response rates. Who this helps: This helps melanoma patients undergoing immunotherapy.

Plain English
This study looked at how COVID-19 (caused by the SARS-CoV-2 virus) affects patients with inflammatory bowel disease (IBD) who are receiving biological treatments. It found that nearly the same percentage of patients with COVID-19 (11.6%) and those without it (11.3%) experienced a worsening of their IBD. However, a significant number of COVID-19 patients—almost half (48.4%)—had to stop their biological therapy, compared to just 3.7% of those without the virus. Who this helps: This research benefits IBD patients and their doctors by clarifying the impact of COVID-19 on their treatment and disease management.

Plain English
This study looks at how the bacteria in our intestines (gut microbiota) can affect anxiety and depression. Researchers found that gut bacteria can influence our mood and behavior, and some treatments such as probiotics have shown promise in improving symptoms for patients. This matters because finding new ways to treat mental health issues could help those who don’t respond well to standard medications. Who this helps: Patients with anxiety and depression.

Plain English
This research examined the relationship between gut bacteria and diverticular disease, which is a common digestive issue in developed countries. It found that an imbalance in gut bacteria may play a significant role in the onset of diverticular disease symptoms. The study also discussed how using probiotics could be a useful treatment to restore healthy gut bacteria. Who this helps: This helps patients with diverticular disease and healthcare providers looking for effective treatments.

Plain English
This study looked at a 21-year-old man with IPEX syndrome, a rare genetic disorder that disrupts the immune system, causing severe symptoms like weight loss and skin issues. After struggling with other treatments, he was given a drug called dupilumab, which led to a rapid improvement in his bowel and skin symptoms. This is significant because it shows that dupilumab can effectively manage IPEX syndrome, offering a new treatment option that reduces the need for steroids. Who this helps: This helps patients with IPEX syndrome and their doctors by providing a new treatment avenue.

Plain English
The research studied how eating tomato sauce made from hydroponically grown tomatoes affects people with Systemic Nickel Allergy Syndrome (SNAS), a condition that requires a strict low-nickel diet. The study found that participants who ate the hydroponic tomato sauce reported significantly fewer symptoms like bloating and constipation compared to those who ate tomatoes grown conventionally. Additionally, their quality of life improved after consuming the hydroponic sauce. Who this helps: This benefits patients with Systemic Nickel Allergy Syndrome trying to manage their symptoms and improve their quality of life.

Plain English
Researchers studied how gastrointestinal (GI) problems are related to autism spectrum disorder (ASD) and the role of gut bacteria in these issues. They found that many individuals with ASD experience GI symptoms like constipation, diarrhea, and abdominal pain, and that changes in gut bacteria are linked to these symptoms. This matters because improving gut health may help alleviate some of the discomfort experienced by ASD patients and lead to better overall health. Who this helps: This helps individuals with autism and their families by addressing GI issues that affect their quality of life.

Plain English
This research looked at how changes in gut bacteria might affect mental health, particularly in people with psychiatric disorders. It found that when people's gut microbiota is imbalanced, it is linked to issues like depression and anxiety. The technique called fecal microbiota transplantation (FMT), which involves transferring stool from a healthy donor to someone with mental health issues, shows promise in restoring gut health and improving symptoms, but there are still many questions to answer before it can be widely used. Who this helps: This helps patients with psychiatric disorders, particularly those struggling with depression and anxiety.

Plain English
This study looked at how well fecal microbiota transplantation (FMT) works for patients with inflammatory bowel disease (IBD) who keep getting Clostridium difficile infections (CDI). Out of 18 patients treated, 17 were free of the infection after 8 weeks, and 83% of them also felt better in terms of their IBD symptoms. This matters because it shows that FMT can effectively fight both the infection and IBD symptoms without serious side effects. Who this helps: This helps patients with inflammatory bowel disease who suffer from recurrent CDI.

Plain English
This study looked at how COVID-19 might lead to irritable bowel syndrome (IBS) in some people. Researchers found that changes in the gut caused by the virus could result in symptoms like stomach pain and diarrhea after recovery from COVID-19. This is important because it highlights the need for awareness and management of gastrointestinal issues that may arise following a COVID-19 infection. Who this helps: This helps patients who experience gastrointestinal problems after recovering from COVID-19.

Plain English
Researchers looked at how taking lactobacilli, a type of beneficial bacteria found in dairy products, might help prevent colorectal cancer (CRC) in animal models. They found that using lactobacilli significantly reduced the risk of CRC and related lesions, showing promising results in the studies reviewed. This is important because colorectal cancer is a major health threat and finding effective preventive measures can save lives. Who this helps: This helps patients at risk for colorectal cancer.

Plain English
This research paper looks at how being critically ill, like with sepsis or organ failure, affects the body’s helpful bacteria, leading to an imbalance that might worsen patient outcomes. It highlights that using treatments targeting these bacteria—like prebiotics, probiotics, and fecal transplants—could improve recovery in the Intensive Care Unit (ICU). Understanding and applying these microbiome-focused treatments may help reduce the negative effects of critical illnesses on patients' health. Who this helps: This helps patients in the ICU and the doctors caring for them.

Plain English
This study examined how the COVID-19 pandemic affected the treatment of patients with inflammatory bowel disease (IBD) at a busy hospital in Italy. Researchers found that while 65% of the 1,451 patients were able to keep their treatment appointments without issues, 20% experienced delays due to personal decisions or logistical problems, and some patients even opted to get their medication closer to home. This is important because it highlights the challenges that patients faced in managing their disease during the pandemic, helping healthcare systems better support them in the future. Who this helps: This benefits IBD patients and their healthcare providers.

Plain English
This study looked at how to choose the best stool donors for fecal microbiota transplantation (FMT), a treatment that uses healthy bacteria from donors to help patients recover from infections and other gut issues. Researchers found that certain bacteria in stool can lead to better outcomes for conditions like recurrent infections and inflammatory bowel disease. This is important because selecting the right donor can improve the success of FMT and better target specific health problems. Who this helps: This benefits patients with gut-related conditions and doctors who perform FMT.

Plain English
This study looked at how the COVID-19 pandemic affected endoscopic procedures for patients with inflammatory bowel disease (IBD) in a busy hospital in Italy. The hospital had to make major changes to their procedures due to the pandemic, leading to a decrease in endoscopic activities. These adjustments were necessary to keep patients and healthcare workers safe during a time when COVID-19 cases were high. Who this helps: This helps patients with IBD and their healthcare providers.

Plain English
This study looked at how common stomach and digestive problems are among people in the West who have COVID-19. Researchers found that over 40% of COVID-19 patients reported symptoms like diarrhea, nausea, or abdominal pain. This matters because understanding these symptoms can help improve care for COVID-19 patients and guide doctors in treatment. Who this helps: Patients with COVID-19 and their healthcare providers.

Plain English
This study looked at how fecal microbiota transplantation (FMT) can help treat diarrhea caused by a type of cancer medication in patients with advanced kidney cancer. They found that patients who received FMT from healthy donors experienced significant relief from diarrhea, with improvements seen four weeks after treatment. Importantly, there were no serious side effects from either treatment. Who this helps: This benefits patients with metastatic renal cell carcinoma who suffer from diarrhea due to their cancer treatment.

Plain English
This study looked at how the bacteria Helicobacter pylori might affect health beyond just the stomach. Researchers found strong links showing that H. pylori infection could be related to conditions like metabolic syndrome and cardiovascular disease. They also noted that people with inflammatory bowel disease (IBD) seem to have lower rates of H. pylori infection, suggesting a complex relationship that still needs more research. Who this helps: This information benefits doctors and patients dealing with gastrointestinal and metabolic health issues.

Plain English
This study looked at how doctors continued to provide fecal microbiota transplants (FMT) as a treatment for Clostridioides difficile infections (CDI) during the COVID-19 pandemic. Out of 26 patients referred for FMT, 21 received the treatment, and none experienced a recurrence of CDI after following up for eight weeks. This is important because it shows that FMT can still be safely and effectively delivered even during a global health crisis. Who this helps: This benefits patients suffering from recurrent CDI.

Plain English
Researchers studied the role of gut bacteria and their impact on both gut health and overall body health. They found that changes in these bacteria can contribute to various health issues, and approaches like changing diets or using probiotics can help restore a healthier balance. Understanding and managing our gut microbiota is important for treating conditions ranging from digestive disorders to mental health issues. Who this helps: This benefits patients with gastrointestinal and other health disorders.